InvestorsHub Logo
Followers 3
Posts 309
Boards Moderated 0
Alias Born 12/27/2016

Re: None

Friday, 08/30/2019 10:39:22 PM

Friday, August 30, 2019 10:39:22 PM

Post# of 140478
With the shares issued yesterday and remaining shares aspire can pick up we would be looking at around 75m os fully diluted come mid 2020. By then warrant money should be funding H2 2020 as we wait for fda approval. I guess add in bonuses and extra. Lets say were at 80m os to use for early b.o. offers. Of course anything can happen but if we remain on sched etc is this reasonable? Would the full 35m from aspire take us to fda submission mid 2020?